Shares of Ambu A/S (OTCMKTS:AMBBY – Get Free Report) reached a new 52-week low on Thursday . The company traded as low as $14.35 and last traded at $15.24, with a volume of 1500 shares trading hands. The stock had previously closed at $15.63.
Ambu A/S Price Performance
The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.47 and a current ratio of 2.49. The company has a 50-day moving average price of $17.24 and a 200-day moving average price of $18.84. The firm has a market capitalization of $3.58 billion and a P/E ratio of 126.96.
Ambu A/S Announces Dividend
The business also recently announced a dividend, which will be paid on Monday, December 23rd. Shareholders of record on Friday, December 6th will be issued a dividend of $0.0557 per share. The ex-dividend date of this dividend is Friday, December 6th. Ambu A/S’s dividend payout ratio (DPR) is currently 25.00%.
About Ambu A/S
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.
Further Reading
- Five stocks we like better than Ambu A/S
- How is Compound Interest Calculated?
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- What Are Dividend Contenders? Investing in Dividend Contenders
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Retail Stocks Investing, Explained
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.
